Lupus & antiphospholipid syndrome

Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort

LupusPublished Cross-sectional study

Authors' conclusion

Vasomotor phenomena are importantly related to ocular symptoms in PAPS. Vascular tortuosity was a frequent finding in PAPS patients. Peripheral vascular tortuosity was associated with triple positivity and might be a biomarker of ischemic microvascular retinopathy due to PAPS.

Study context

Population
Patients with primary APS in the APS-Rio cohort and healthy controls
Participants
98 vs 102
Exposure
Primary APS vs healthy controls
  • Primary antiphospholipid syndrome (PAPS)n = 98
  • Controlsn = 102reference
Outcome
Ophthalmological manifestations
Methodological detailshealthy control group, extensive ophthalmological evaluation
  • Healthy control group
  • Extensive ophthalmological evaluation

Main finding

As reported in the abstract

Ocular findings
Amaurosis fugax (most common symptom in PAPS), PAPS vs controls
34.7% vs. 6.9%; p = .001
PAPS patients with ocular involvement
84
Glaucoma in PAPS
1.0%
Posterior findings in PAPS
94.0%
Anterior findings in PAPS
62.7%
Both posterior and anterior findings in PAPS
56.6%
Vascular tortuosity, PAPS vs controls
63.2% vs. 42.2%; p = .002
Peripheral tortuosity, PAPS vs controls
29.6% vs. 7.8%; p < .001

Observational data: associations, not effects.

Further findings

OutcomePAPSControlsP value
Peripheral vascular tortuosity after excluding patients with atherosclerotic risk factors35.07.8%P < 0.001

Factors associated with ocular symptoms in PAPS (multivariate analyses)

Raynaud's phenomenon and amaurosis fugax
OR 3.71, CI:1.33-10.32; p = .012
Livedo and hemianopia
OR 6.96, CI:1.11-43.72, p = .038
Livedo and diplopia
OR 3.49, CI:1.02-11.53, p = .047

Triple positivity in PAPS with vs without peripheral vascular tortuosity

With vs without peripheral vascular tortuosity
34.5% vs. 15.9%, p = .041

Original publication

Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort. Lupus. Published 29 November 2022. doi:10.1177/09612033221143294

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.